Correlation Between Amicus Therapeutics and Mereo BioPharma

Can any of the company-specific risk be diversified away by investing in both Amicus Therapeutics and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amicus Therapeutics and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Amicus Therapeutics and Mereo BioPharma Group, you can compare the effects of market volatilities on Amicus Therapeutics and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amicus Therapeutics with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amicus Therapeutics and Mereo BioPharma.

Diversification Opportunities for Amicus Therapeutics and Mereo BioPharma

0.78

Correlation Coefficient

Amicus Therapeutics  Mereo BioPharma

Poor diversification

The 3 months correlation between Amicus and Mereo is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Amicus Therapeutics and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Amicus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amicus Therapeutics are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Amicus Therapeutics i.e., Amicus Therapeutics and Mereo BioPharma go up and down completely randomly.

Pair Corralation between Amicus Therapeutics and Mereo BioPharma

Given the investment horizon of 90 days Amicus Therapeutics is expected to under-perform the Mereo BioPharma. But the stock apears to be less risky and, when comparing its historical volatility, Amicus Therapeutics is 1.56 times less risky than Mereo BioPharma. The stock trades about -0.04 of its potential returns per unit of risk. The Mereo BioPharma Group is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  309.00  in Mereo BioPharma Group on October 9, 2024 and sell it today you would earn a total of  67.00  from holding Mereo BioPharma Group or generate 21.68% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Amicus Therapeutics  vs.  Mereo BioPharma Group

Amicus Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Amicus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound essential indicators, Amicus Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Mereo BioPharma Group

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Mereo BioPharma is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Amicus Therapeutics and Mereo BioPharma

The main advantage of trading using opposite Amicus Therapeutics and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amicus Therapeutics position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.

The idea behind Amicus Therapeutics and Mereo BioPharma Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.